New Year's Summiteers

Photograph courtesy of Pamela Wolfe Crimson hikers (from left) Anne Walston ’67, Éva Borsody Das ’63, and Ken Moller...

Photograph courtesy of Pamela Wolfe

Crimson hikers (from left) Anne Walston ’67, Éva Borsody Das ’63, and Ken Moller ’69 spent early 2008 in Tanzania, climbing Mount Kilimanjaro, Africa’s tallest peak, in an international group sponsored by the Appalachian Mountain Club. To combat altitude sickness, the trekkers took six days to ascend; they needed only a day and a half to return to base camp. They spent about 20 minutes on the summit. “I don’t remember a lot of it,” Das told her Massachusetts hometown paper, the Hull Times. “Your brain cells are dying. I don’t remember the wind or the cold.” She’d already gone climbing again, in the Catskills.

Related topics

You might also like

A History of Harvard Magazine

Harvard’s independent alumni magazine—at 127 years old 

Parks and Rec Comedy Writer Aisha Muharrar Gets Serious about Grief

With Loved One, the Harvard grad and Lampoon veteran makes her debut as a novelist.

A New Prescription for Youth Mental Health

Kenyan entrepreneur Tom Osborn ’20 reimagines care for a global crisis.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

The Life of a Harvard Spy

Richard Skeffington Welch’s illustrious—and clandestine—career in the CIA

Harvard Alumni Affairs Databases Breached

The University is investigating the cyberattack, which may have compromised the personal information of alumni, donors, students, faculty, and staff.

Explore More From Current Issue

Wolfram Schlenker wearing a suit sitting outdoors, smiling, with trees and a building in the background.

Harvard Economist Wolfram Schlenker Is Tackling Climate Change

How extreme heat affects our land—and our food supply 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.